Tags

Type your tag names separated by a space and hit enter

[The role of stereotactic 11G vacuum biopsy for clarification of BI-RADS IV findings in mammography].
Rofo. 2003 Apr; 175(4):489-94.ROFO

Abstract

PURPOSE

To evaluate the potential of stereotactic vacuum breast biopsy in the histologic evaluation of suspicious mammographic findings (BI-RADS IV).

MATERIALS AND METHODS

In 221 patients with 227 probable mammographic lesions categorized as (BI-RADS -IV), stereotactic biopsies were performed with an 11-gauge vacuum-assisted biopsy device (Mammotome). The evaluation included the histology of the specimens obtained with the Mammotome or with surgery, the time for the biopsy, the amount of bleeding, number of rotations and procured specimens, the extent of the resection and the complications.

RESULTS

The biopsies were technically successful in 214 of the 227 probable mammographic lesions, with 176 lesions mostly resected and 34 lesions removed more than 50 %. No representative tissue was obtained from 4 lesions. All biopsies were performed without any clinically relevant complications and terminated after adequate material was obtained (O 28 specimens, 2.58 rotations). The mean time needed for performing the biopsy was 40.2 minutes. The histologic findings were DCIS (42 lesions), ADH (7 lesions), LCIS (3 lesions), ID-Ca (14 lesions, IL-Ca (3 lesions), and IDL-Ca (1 lesion). In 28 of 42 lesions with the initial DCIS histology, the surgical histology was also DCIS (n=28) or no residual tumor (n=10). In 4 lesions with an initial DCIS-histology, the surgical histology was invasive ductal cancer (9.5 %). The late follow-up examinations (up to 3 years) did not find any evidence of a false negative biopsy.

CONCLUSION

Stereotactic vacuum breast biopsy ideally complements existing breast biopsy methods. The method is minimal invasive with a low rate of mostly minor complications.

Authors+Show Affiliations

Institut für Diagnostische und Interventionelle Radiologie, Klinikum der J.W.G.-Universität Frankfurt/Main.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

12677503

Citation

Diebold, T, et al. "[The Role of Stereotactic 11G Vacuum Biopsy for Clarification of BI-RADS IV Findings in Mammography]." RoFo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, vol. 175, no. 4, 2003, pp. 489-94.
Diebold T, Jacobi V, Krapfl E, et al. [The role of stereotactic 11G vacuum biopsy for clarification of BI-RADS IV findings in mammography]. Rofo. 2003;175(4):489-94.
Diebold, T., Jacobi, V., Krapfl, E., von Minckwitz, G., Solbach, C., Ballenberger, S., Hochmuth, K., Balzer, J. O., Fellbaum, M., Kaufmann, M., & Vogl, T. J. (2003). [The role of stereotactic 11G vacuum biopsy for clarification of BI-RADS IV findings in mammography]. RoFo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, 175(4), 489-94.
Diebold T, et al. [The Role of Stereotactic 11G Vacuum Biopsy for Clarification of BI-RADS IV Findings in Mammography]. Rofo. 2003;175(4):489-94. PubMed PMID: 12677503.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [The role of stereotactic 11G vacuum biopsy for clarification of BI-RADS IV findings in mammography]. AU - Diebold,T, AU - Jacobi,V, AU - Krapfl,E, AU - von Minckwitz,G, AU - Solbach,C, AU - Ballenberger,S, AU - Hochmuth,K, AU - Balzer,J O, AU - Fellbaum,M, AU - Kaufmann,M, AU - Vogl,T J, PY - 2003/4/5/pubmed PY - 2003/6/5/medline PY - 2003/4/5/entrez SP - 489 EP - 94 JF - RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin JO - Rofo VL - 175 IS - 4 N2 - PURPOSE: To evaluate the potential of stereotactic vacuum breast biopsy in the histologic evaluation of suspicious mammographic findings (BI-RADS IV). MATERIALS AND METHODS: In 221 patients with 227 probable mammographic lesions categorized as (BI-RADS -IV), stereotactic biopsies were performed with an 11-gauge vacuum-assisted biopsy device (Mammotome). The evaluation included the histology of the specimens obtained with the Mammotome or with surgery, the time for the biopsy, the amount of bleeding, number of rotations and procured specimens, the extent of the resection and the complications. RESULTS: The biopsies were technically successful in 214 of the 227 probable mammographic lesions, with 176 lesions mostly resected and 34 lesions removed more than 50 %. No representative tissue was obtained from 4 lesions. All biopsies were performed without any clinically relevant complications and terminated after adequate material was obtained (O 28 specimens, 2.58 rotations). The mean time needed for performing the biopsy was 40.2 minutes. The histologic findings were DCIS (42 lesions), ADH (7 lesions), LCIS (3 lesions), ID-Ca (14 lesions, IL-Ca (3 lesions), and IDL-Ca (1 lesion). In 28 of 42 lesions with the initial DCIS histology, the surgical histology was also DCIS (n=28) or no residual tumor (n=10). In 4 lesions with an initial DCIS-histology, the surgical histology was invasive ductal cancer (9.5 %). The late follow-up examinations (up to 3 years) did not find any evidence of a false negative biopsy. CONCLUSION: Stereotactic vacuum breast biopsy ideally complements existing breast biopsy methods. The method is minimal invasive with a low rate of mostly minor complications. SN - 1438-9029 UR - https://www.unboundmedicine.com/medline/citation/12677503/[The_role_of_stereotactic_11G_vacuum_biopsy_for_clarification_of_BI_RADS_IV_findings_in_mammography]_ DB - PRIME DP - Unbound Medicine ER -